Drug Profile
Research programme: calcitonin gene-related peptide receptor antagonists - Merck
Alternative Names: CGRP receptor antagonists - Merck; Imidazoazepanes - Merck; MK-2918; MK-8825Latest Information Update: 18 May 2020
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Piperidines; Small molecules; Spiro compounds
- Mechanism of Action Calcitonin gene-related peptide receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Migraine